Cubist Systematic Strategies’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
RSCM
PAMP
Cubist Systematic Strategies's XENT Position: Q2 2021 in Review
Cubist Systematic Strategies sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 18,603 shares — an estimated $388K sold.
Cubist Systematic Strategies first reported a position in XENT in Q3 2014 and held it in 18 quarters. The position peaked at $469K in Q2 2018. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.
- Cubist Systematic Strategies reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
- Cubist Systematic Strategies sold 18,603 Intersect ENT, Inc shares in Q2 2021, an estimated $388K.
- Cubist Systematic Strategies first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 18 quarters.
- Cubist Systematic Strategies's Intersect ENT, Inc position peaked at $469K in Q2 2018.
- 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.